Document is current
Any future updates will be listed below
-
Authors
Kessler, Alaina J. https://orcid.org/0000-0001-9058-5118
Patel, Rima
Gallagher, Emily Jane
Sheng, Tianxiang
Mendu, Damodara Rao
Tiersten, Amy
Klein, Paula
Bhardwaj, Aarti S.
Goel, Anupama
Sparano, Joseph A.
Shao, Theresa
Fasano, Julie
-
Funding
Funding for this research was provided by:
National Institutes of Health (R37CA266853, 5UG1CA189859)
Pfizer
Novartis Pharmaceuticals Corporation
Eli Lilly and Company
Breast Cancer Research Foundation
Susan G. Komen for the Cure
V Foundation
- License Information
-
More Information
Article History
Received: 19 May 2024
Accepted: 15 July 2024
First Online: 7 August 2024
Declarations
:
: Dr. Gallagher is a consultant for Novartis, Flare Therapeutics, Seagen, and SynDevRx. Dr. Tiersten is a consultant for AstraZeneca. Dr. Sparano is a consultant for AstraZeneca, Bristol Myers Squibb, Eisai, GE, Eli Lilly, Exact Sciences, Lyell, Novartis, Roche, Sanofi, and Seagen. Dr. Fasano is on the advisory board for Magellan Health. The other authors have no relevant financial or non-financial interests to disclose.
: This study was approved by the Icahn School of Medicine at Mount Sinai Institutional Review Board.
: Informed consent was waived by the Icahn School of Medicine at Mount Sinai Institutional Review Board.
